Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Asset Utilization Ratio (2020 - 2025)

Fennec Pharmaceuticals (FENC) has disclosed Asset Utilization Ratio for 6 consecutive years, with 0.82 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Asset Utilization Ratio rose 1.94% year-over-year to 0.82, compared with a TTM value of 0.82 through Sep 2025, up 1.94%, and an annual FY2024 reading of 1.32, up 67.6% over the prior year.
  • Asset Utilization Ratio was 0.82 for Q3 2025 at Fennec Pharmaceuticals, up from 0.73 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.94 in Q1 2024 and bottomed at 0.03 in Q4 2022.
  • Average Asset Utilization Ratio over 5 years is 0.41, with a median of 0.37 recorded in 2023.
  • The sharpest move saw Asset Utilization Ratio plummeted 113.5% in 2022, then surged 176819.87% in 2023.
  • Year by year, Asset Utilization Ratio stood at 0.01 in 2021, then tumbled by 479.05% to 0.03 in 2022, then skyrocketed by 2777.18% to 0.91 in 2023, then increased by 0.88% to 0.92 in 2024, then dropped by 9.97% to 0.82 in 2025.
  • Business Quant data shows Asset Utilization Ratio for FENC at 0.82 in Q3 2025, 0.73 in Q2 2025, and 0.68 in Q1 2025.